Researchmoz Global Pvt. Ltd.

Research Report on Indian Immunologicals Limited - Product Pipeline Review – 2015

Most up-to-date research on "Indian Immunologicals Limited - Product Pipeline Review - 2015" to its huge collection of research reports.

 

Albany, NY -- (SBWIRE) -- 05/26/2015 -- Global Markets Directs, Indian Immunologicals Limited Product Pipeline Review 2015, provides an overview of the Indian Immunologicals Limiteds pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Indian Immunologicals Limiteds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Browse Detail Report With TOC
http://www.researchmoz.us/indian-immunologicals-limited-product-pipeline-review-2015-report.html

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Request for Sample Report
http://www.researchmoz.com/enquiry.php?type=sample&repid=283520

Scope

The report provides brief overview of Indian Immunologicals Limited including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Indian Immunologicals Limiteds human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Indian Immunologicals Limiteds pipeline products

Reasons to buy

Evaluate Indian Immunologicals Limiteds strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Indian Immunologicals Limited in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Indian Immunologicals Limiteds R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Indian Immunologicals Limited and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Indian Immunologicals Limited

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Indian Immunologicals Limited and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

For Market Research Latest Reports Visit
http://www.researchmoz.us/latest-report.html

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Indian Immunologicals Limited Snapshot 5
Indian Immunologicals Limited Overview 5
Key Information 5
Key Facts 5
Indian Immunologicals Limited - Research and Development Overview 6
Key Therapeutic Areas 6
Indian Immunologicals Limited - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Combination Treatment Modalities 10
Indian Immunologicals Limited - Pipeline Products Glance 11
Indian Immunologicals Limited - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Indian Immunologicals Limited - Unknown Stage Pipeline Products 12
Unknown Products/Combination Treatment Modalities 12
Indian Immunologicals Limited - Drug Profiles 13
diphtheria + pertussis + tetanus + hepatitis B + haemophilus influenza [serotype B] vaccine 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
haemophilus influenzae vaccine [type B] 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
human papilloma virus vaccine [types 16 and 18] 15
Product Description 15
Mechanism of Action 15

Related Reports

Ureter Cancer - Pipeline Review H1 2015

(http://www.researchmoz.us/ureter-cancer-pipeline-review-h1-2015-report.html)

Ureter Cancer - Pipeline Review, H1 2015 Summary Global Markets Directs, Ureter Cancer - Pipeline Review, H1 2015, provides an overview of the Ureter Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Ureter Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action...

Pancreatic Endocrine Tumor - Pipeline Review H1 2015

(http://www.researchmoz.us/pancreatic-endocrine-tumor-pipeline-review-h1-2015-report.html)

Pancreatic Endocrine Tumor - Pipeline Review, H1 2015 Summary Global Markets Directs, Pancreatic Endocrine Tumor - Pipeline Review, H1 2015, provides an overview of the Pancreatic Endocrine Tumors therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pancreatic Endocrine Tumor, complete with comparative analysis at various stages,...

Browse Our Press Releases on Prnewswire
http://www.prnewswire.com/news/researchmoz

About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:
Tel: 518-618-1030
Toll Free: 866-997-4948
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Email: sales@researchmoz.us